2. As of noon trading, DaVita HealthCare Partners ( DVA) is up $1.47 (1.2%) to $121.50 on average volume Thus far, 461,581 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 868,000 shares. The stock has ranged in price between $119.78-$121.79 after having opened the day at $119.98 as compared to the previous trading day's close of $120.03.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $11.4 billion and is part of the health care sector. The company has a P/E ratio of 21.7, above the S&P 500 P/E ratio of 17.7. Shares are up 8.2% year to date as of the close of trading on Friday. Currently there are 10 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, increase in net income, good cash flow from operations and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full DaVita HealthCare Partners Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you liked this article you might like

These Stocks Are Ready to Reverse Course

The 10% Pop in H&R Block Has Nothing to Do With the Fed

Fed Has Nothing to Do With the 10% Pop in H&R Block

Analysts' Actions -- Adobe, Starbucks, Snap, KB Home and More

Brookdale Is Exploring Its Options